Enzalutamide was found to decrease the risk of skeletal-related events in men with metastatic castration-resistant prostate cancer.
Recommendations are for men whose tumors have grown resistant to hormonal therapies were issued jointly by the American Society of Clinical Oncology (ASCO) and Cancer Care Ontario (CCO) in Canada.
There has been widespread adoption in the United States of robot-assisted prostatectomy to treat prostate cancer in recent years.
African American men may not benefit from watchful waiting after being diagnosed with low-grade prostate cancer.
Researchers have designed a new, non-invasive technique to screen for prostate cancer.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|